BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20066497)

  • 1. Chemotherapy resistance research of lung cancer based on micro-fluidic chip system with flow medium.
    Zhao L; Wang Z; Fan S; Meng Q; Li B; Shao S; Wang Q
    Biomed Microdevices; 2010 Apr; 12(2):325-32. PubMed ID: 20066497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a double-layer microfluidic chip with flow medium for chemotherapy resistance analysis of lung cancer.
    Meng Q; He Z; Zhang L; Zhao L; Li E; Zhang Q; Zhang X; Yang D; Zou L; Gao Z; Wang Q
    Electrophoresis; 2011 Nov; 32(23):3446-53. PubMed ID: 22072486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of chemoresistance in lung cancer with a simple microfluidic device.
    Zhang L; Wang J; Zhao L; Meng Q; Wang Q
    Electrophoresis; 2010 Nov; 31(22):3763-70. PubMed ID: 20949633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of microfluidic gradient chip in the analysis of lung cancer chemotherapy resistance.
    Siyan W; Feng Y; Lichuan Z; Jiarui W; Yingyan W; Li J; Bingcheng L; Qi W
    J Pharm Biomed Anal; 2009 Apr; 49(3):806-10. PubMed ID: 19162424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The analysis of chemotherapy resistance in human lung cancer cell line with microchip-based system.
    Ying-Yan W; Tao W; Xin L; Hong-Wei G; Bing-Cheng L; Qi W
    Biomed Microdevices; 2008 Jun; 10(3):429-35. PubMed ID: 18368495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of P-glycoprotein is associated with resistance to cisplatin and VP-16 in human lung cancer cell lines.
    Wang J; Wang H; Zhao L; Fan S; Yang Z; Gao F; Chen L; Xiao GG; Molnár J; Wang Q
    Anticancer Res; 2010 Sep; 30(9):3593-8. PubMed ID: 20944142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis.
    Chiu CC; Lin CH; Fang K
    Apoptosis; 2005 May; 10(3):643-50. PubMed ID: 15909125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells.
    Oizumi S; Isobe H; Ogura S; Ishida T; Yamazaki K; Nishimura M; Kawakami Y; Dosaka-Akita H
    Anticancer Res; 2002; 22(6C):4029-37. PubMed ID: 12553028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
    Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An osmotic micro-pump integrated on a microfluidic chip for perfusion cell culture.
    Xu ZR; Yang CG; Liu CH; Zhou Z; Fang J; Wang JH
    Talanta; 2010 Jan; 80(3):1088-93. PubMed ID: 20006057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer.
    Wesarg E; Hoffarth S; Wiewrodt R; Kröll M; Biesterfeld S; Huber C; Schuler M
    Int J Cancer; 2007 Dec; 121(11):2387-94. PubMed ID: 17688235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRP78 upregulation-induced increase in cisplatin sensitivity of SPCA1 lung cancer cells.
    Zhang LC; Wang JR; Zhao L; Wang T; Wu J; Fan SF; Chen LX; Shao SJ; Molnár J; Wang Q
    Chin Med J (Engl); 2011 Oct; 124(20):3341-6. PubMed ID: 22088532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy in non-small cell bronchial carcinoma. 12 years' experience in an international cooperative group: EORTC Lung Cancer Working Party].
    Lacroix H; Sculier JP
    Bull Cancer; 1990; 77(10):997-1005. PubMed ID: 2174277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells.
    Chiu CC; Li CH; Ung MW; Fuh TS; Chen WL; Fang K
    Cancer Lett; 2005 Jun; 223(2):249-58. PubMed ID: 15896459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines.
    Balcer-Kubiczek EK; Attarpour M; Edelman MJ
    Cancer Chemother Pharmacol; 2007 May; 59(6):781-7. PubMed ID: 16957930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of radiotherapy in the framework of curative chemotherapy concept in local advanced non-small-cell bronchial carcinoma].
    Plasswilm L
    Strahlenther Onkol; 1995 May; 171(5):306-8. PubMed ID: 7770790
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer.
    Mukhopadhyay NK; Weisberg E; Gilchrist D; Bueno R; Sugarbaker DJ; Jaklitsch MT
    Ann Thorac Surg; 2006 Mar; 81(3):1034-42. PubMed ID: 16488717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.
    Dantzig AH; Shepard RL; Cao J; Law KL; Ehlhardt WJ; Baughman TM; Bumol TF; Starling JJ
    Cancer Res; 1996 Sep; 56(18):4171-9. PubMed ID: 8797588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.